Menu

Is Immunotherapy Living Up to Its Promise?

The Scientist is bringing together a panel of experts to weigh in on the progress that immunotherapy has made.

Jul 18, 2017
The Scientist Creative Services Team

Is Immunotherapy Living up to Its Promise? from thescientistllc on Vimeo

Immunotherapy has been hailed as a breakthrough for treating the untreatable, but it has not yet lived up to its promise to eradicate cancer and infectious disease. While there have been a number of exciting advances, there are still several real-world hurdles for immunotherapy to surmount before it becomes a standard option for most patients. The Scientist is bringing together a panel of experts to weigh in on the progress that immunotherapy has made, particularly in the search for effective anticancer treatments, and to discuss the steps still needed before immunotherapy becomes standard treatment in the clinic. Attendees will have the opportunity to interact with the experts, ask questions, and seek advice on topics that are related to their research.

Topics to be covered:

  • Where immunotherapies have succeeded, and where they have failed
  • Current progress in immunotherapy research, development, and deployment

View the Video Now

Meet the Speakers:

Jill O’Donnell-Tormey, PhD
CEO and Director of Scientific Affairs
Cancer Research Institute

 

 

 

 

Alex Y. Huang, MD, PhD
Professor, Departments of Pediatrics,
Pathology, Biomedical Engineering,
and General Medical Sciences,
Case Western Reserve University School of Medicine,
UH Rainbow Babies & Children's Hospital

 

 


 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening